2: Connecting the Dots: Why You Should Consider Continuous
Is continuous the way to go? Avril Vermunt discusses the benefits over batch, the first things to consider, and common pitfalls when connecting your process.
Interviewee Biography
Avril Vermunt - Strategic Technology Partnership Leader, Cytiva
Avril is an innovative team and program leader in the biomanufacturing industry, with expertise in process development, design, scale-up, and engineering. Since joining Cytiva in 2015, she has contributed to the Commercial and Bioprocess organizations by driving customer collaboration and delivering impactful engagement, digital awareness, and value-driven solutions. Prior to this, she had roles in Amgen Process Development and Fujifilm Diosynth, where she gained extensive experience in commercial and clinical manufacturing processes, as well as capital projects.
Avril loves channeling her 20+ years of experience towards strategic partnerships, with a focus on intensified processes to enable next-generation manufacturing, and improving patient accessibility and affordability.
Related Information
4 Steps Toward End-To-End Connected Manufacturing
Cytiva’s process intensification solutions
Watch Cytiva’s digital series documenting a connected closed mAb process
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE!